Why the study?
Are mutations in the desmoglein-2 (DSG2) gene associated with arrhythmogenic right ventricular cardiomyopathy?
Population
80 unrelated probands with arrhythmogenic right ventricular cardiomyopathy fulfilling task force criteria
Design
Cross-sectional
Authors
Loading...
DSG2 variants may inform ARVC genetic panels; supports desmosomal role yet leaves causality open in level 4 data.
Are mutations in the desmoglein-2 (DSG2) gene associated with arrhythmogenic right ventricular cardiomyopathy?
This study identifies DSG2 as a causative gene for ARVC, confirming that many forms of the disease are driven by desmosomal complex alterations.
Pilichou et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: